HIV and Cardiovascular Disease: A Growing Concern

Cardiovascular disease (CVD) is increasingly recognized as a significant health threat for individuals living with human immunodeficiency virus (HIV). While advancements in antiretroviral therapy (ART) have dramatically improved survival rates for those with HIV, they haven’t fully eliminated the elevated risk of heart problems. This article explores the complex relationship between HIV and CVD, the underlying mechanisms, and current understanding of managing this dual health challenge.

The Link Between HIV and Heart Disease

Individuals with HIV are at a higher risk of developing various cardiovascular complications compared to age-matched individuals without HIV. These complications include coronary heart disease, heart failure, arrhythmias, and stroke Circulation. The increased risk isn’t solely due to the virus itself, but likewise to factors associated with HIV infection and its treatment.

How HIV Impacts Cardiovascular Health

Several factors contribute to the increased cardiovascular risk in people living with HIV:

• Immune Activation and Inflammation: HIV infection causes chronic immune activation and inflammation, even in individuals on effective ART. This persistent inflammation contributes to the development of atherosclerosis (plaque buildup in the arteries) PMC.
• Antiretroviral Therapy (ART): While life-saving, some ART regimens have been linked to metabolic abnormalities, including dyslipidemia (abnormal cholesterol levels), insulin resistance, and lipodystrophy (changes in body fat distribution). These metabolic changes increase CVD risk The Cardiology Advisor.
• Traditional Risk Factors: People with HIV often have a higher prevalence of traditional CVD risk factors like hypertension, smoking, and family history of heart disease.
• HIV-Associated Nephropathy: Kidney disease is more common in people with HIV and is a strong risk factor for CVD.

Cardiovascular Manifestations in HIV

HIV infection can manifest in a variety of cardiovascular problems:

• Coronary Heart Disease: The most common CVD manifestation, involving narrowing of the coronary arteries and reduced blood flow to the heart.
• Heart Failure: The heart’s inability to pump enough blood to meet the body’s needs.
• Arrhythmias: Irregular heartbeats.
• Pericardial Disease: Inflammation of the sac surrounding the heart.
• Pulmonary Hypertension: High blood pressure in the arteries of the lungs.

Diagnosis and Management

Early detection and management of CVD in people with HIV are crucial. This includes:

• Regular Screening: Individuals with HIV should undergo regular cardiovascular risk assessments, including blood pressure checks, lipid profiles, and glucose monitoring.
• Lifestyle Modifications: Adopting a heart-healthy lifestyle, including a balanced diet, regular exercise, and smoking cessation, is essential.
• ART Optimization: Selecting ART regimens with a favorable metabolic profile can help minimize CVD risk.
• Management of Comorbidities: Aggressively managing conditions like hypertension, diabetes, and dyslipidemia is vital.
• Cardiac Evaluation: If symptoms suggestive of heart disease develop, a thorough cardiac evaluation, including an electrocardiogram (ECG) and echocardiogram, may be necessary.

The Future of HIV and CVD Research

Ongoing research is focused on understanding the complex interplay between HIV, ART, and cardiovascular health. Studies are investigating novel therapeutic strategies to reduce inflammation and improve vascular function in people living with HIV. Improved understanding of these mechanisms will lead to better prevention and treatment strategies for CVD in this vulnerable population JAMA Internal Medicine.